Laboratory network of excellence: enhancing patient safety and service effectiveness
-
Mario Plebani
Abstract
Clinical laboratories have undergone major changes due to technological progress and economic pressure. While costs of laboratory testing continue to be the dominant issue within the healthcare service worldwide, quality, effectiveness and impact on outcomes are also emerging as critical value-added features. Five Italian laboratories are therefore promoting a network of excellence by investigating markers of effectiveness of laboratory services and sharing their experience of using them in clinical practice. In the present study we report preliminary data on indicators of quality in all phases of the so-called total testing process, the key to evaluating all phases of the total testing process, including the appropriateness of test requests and data interpretation. Initial findings in evaluating pre-analytical causes of specimen rejection in three different laboratories and the effects of introducing three laboratory clinical guidelines are reported. These data should stimulate debate in the scientific community and encourage more clinical laboratories to use the same indicators to improve clinical effectiveness and clinical outcomes within the healthcare service.
References
1. Plebani M. The changing face of clinical laboratories. Clin Chem Lab Med 1999; 37:711–7.10.1515/CCLM.1999.109Search in Google Scholar
2. Gray TA. Clinical governance. Ann Clin Biochem 2000; 37:9–15.10.1258/0004563001901452Search in Google Scholar
3. Plebani M. Role of inspectors in external review mechanisms: criteria for selection, training and appraisal. Clin Chim Acta 2001; 309:147–54.10.1016/S0009-8981(01)00513-7Search in Google Scholar
4. Price CP. Evidence-based laboratory medicine: supporting decision-making. Clin Chem 2000; 46:1041–50.10.1093/clinchem/46.8.1041Search in Google Scholar
5. Waise A, Plebani M. Which surrogate marker can be used to assess the effectiveness of the laboratory and its contribution to clinical outcome? Ann Clin Biochem 2001; 38:589–95.10.1258/0004563011900885Search in Google Scholar
6. Konh LT, Corrigan JM, Donaldson MS. To err is human: building a safer health system. Washington, DC: Academic Press, 2000.Search in Google Scholar
7. Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin Chem 1997; 43:1348–51.10.1093/clinchem/43.8.1348Search in Google Scholar
8. Bonini PA, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin Chem 2002; 48:691–8.10.1093/clinchem/48.5.691Search in Google Scholar
9. Stroobants AK, Goldschmidt HM, Plebani M. Error budget calculations in laboratory medicine: linking the concepts of biological variation and allowable medical errors. Clin Chim Acta 2003; 333:169–76.10.1016/S0009-8981(03)00181-5Search in Google Scholar
10. Holman JW, Mifflin TE, Felder RA, Demers LM. Evaluation of an automated preanalytical robotic workstation at two academic health centers. Clin Chem 2002; 48:540–8.10.1093/clinchem/48.3.540Search in Google Scholar
11. Ricos C, Garcia-Victoria M, de la Fuente B. Quality indicators and specifications for the extra-analytical phases in clinical laboratory management. Clin Chem Lab Med 2004; 42:578–82.10.1515/CCLM.2004.100Search in Google Scholar PubMed
12. Draft Federal Information Processing Standards Publication 183. Integration definition for function modelling (idef). www.Idef.com/Downloads/pdf/idef0.pdf, 1993.Search in Google Scholar
13. Redmill F, Chudleigh M, Catmur J. System safety: HAZOP and Software HAZOP. Chichester: John Wiley & Sons, 1999.10.1007/978-1-4471-0823-8Search in Google Scholar
14. Schraagen JM, Chipman SF, Shalin VL. Cognitive task analysis. Mahwah, NJ: Lawrence Erlbaum Associates, 2000.10.4324/9781410605795Search in Google Scholar
15. Bonini P, Ceriotti F, Gaia M. Total laboratory error: inevitable or avoidable. Clin Chim Acta 2005; 355:s46–7.Search in Google Scholar
16. Proposed ISO/DTR 22367. Medical laboratories – reduction of error through risk management and continual improvement – complementary element. Version 2.1c2. ISO, 2005.Search in Google Scholar
17. Jones BA, Calam RR, Howanitz PJ. Chemistry specimen acceptability. Arch Pathol Lab Med 1997; 121:19–26.Search in Google Scholar
18. Field MJ, Lohr KN, editors. Guidelines for clinical practice. From development to use. Washington, DC: National Academy Press, 1992.Search in Google Scholar
19. Oosterhuis WP, Bruns DE, Watine J, Sandberg S, Horvath AR. Evidence-based guidelines in laboratory medicine: principles and methods. Clin Chem 2004; 50:806–18.10.1373/clinchem.2003.025528Search in Google Scholar
20. Demers EM, Spencer CA. Laboratory support for the diagnosis and monitoring of thyroid disease. The National Academy of Clinical Biochemistry, 2003 (http://www.nacb.org/lmpg/thyroid_lmpg_pub.stm).10.1046/j.1365-2265.2003.01681.xSearch in Google Scholar
21. Hamm CW, Bertrand M, Braunwald E. Acute coronary syndrome without ST elevation: implementation of new guidelines. Lancet 2001; 358:1533–8.10.1016/S0140-6736(01)06585-0Search in Google Scholar
22. Tozzoli R, Bizzaro N, Tonutti E, Villalta D, Bassetti D, Manoni F, et al. Guidelines for the laboratory use of autoantibody tests in the diagnosis and monitoring of autoimmune rheumatic diseases. Am J Clin Pathol 2002; 117:316–24.10.1309/Y5VF-C3DM-L8XV-U053Search in Google Scholar PubMed
23. ISO 15189. Medical laboratories – particular requirements for quality and competence. ISO, 2003.Search in Google Scholar
24. Laposata M. Patient-specific narrative interpretation of complex clinical laboratory evaluations: who is competent to provide them? Clin Chem 2004; 50:471–2.10.1373/clinchem.2003.028951Search in Google Scholar PubMed
25. Kilpatrick ES. Can the addition of interpretative comments to laboratory reports influence outcome? An example involving patients taking thyroxine. Ann Clin Biochem 2004; 41:227–9.10.1258/000456304323019604Search in Google Scholar PubMed
26. Fraser CG, Hyltoft Petersen P. Analytical performance characteristics should be judged against objective quality specifications. Clin Chem 1999; 45:321–3.10.1093/clinchem/45.3.321Search in Google Scholar
27. Plebani M. What information on quality specifications should be communicated to clinicians, and how? Clin Chim Acta 2004; 346:25–35.10.1016/j.cccn.2004.03.019Search in Google Scholar PubMed
28. Kyle RA, Rajkumar SV. Monoclonal gammopathies of undetermined significance. Rev Clin Exp Hematol 2002; 63:225–52.Search in Google Scholar
29. Carraro P, Servidio G, Plebani M. Hemolyzed specimens: a reason for rejection or a clinical challenge? Clin Chem 2000; 46:306–7.10.1093/clinchem/46.2.306Search in Google Scholar
30. Wilson ML. Appropriate use of clinical microbiology tests. Clin Lab Med 2002; 22:491–503.10.1016/S0272-2712(01)00004-XSearch in Google Scholar
31. Toybert ME, Chevret S, Cassinat B, Schlageter MH, Beressi JP, Rain JD. From guidelines to hospital practice: reducing inappropriate ordering of thyroid hormone and antibody tests. Eur J Endocrinol 200; 142:605–10.10.1530/eje.0.1420605Search in Google Scholar
32. Keren DF. Antinuclear antibody testing. Clin Lab Med 2002; 22:447–74.10.1016/S0272-2712(01)00012-9Search in Google Scholar
33. Howanitz PG, Tetrault GA, Steindel SJ. Clinical laboratory quality control: a costly process now out of control. Clin Chim Acta 1997; 260:163–74.10.1016/S0009-8981(96)06494-7Search in Google Scholar
34. Henny J, Petersen HP. Reference values: from philosophy to a tool for laboratory medicine. Clin Chem Lab Med 2004; 42:686–91.10.1515/CCLM.2004.117Search in Google Scholar
35. Grasbeck R. The evolution of the reference value concept. Clin Chem Lab Med 2004; 42:692–7.10.1515/CCLM.2004.118Search in Google Scholar
36. Plebani M. Charting the course of medical laboratories in a changing environment. Clin Chim Acta 2002; 319:87–100.10.1016/S0009-8981(02)00028-1Search in Google Scholar
37. Fraser CG. Inherent biological variation and reference values. Clin Chem Lab Med 2004; 42:758–64.10.1515/CCLM.2004.128Search in Google Scholar PubMed
38. Forsman RW. Why is the laboratory an afterthought for managed care organizations? Clin Chem 1996; 42:813–6.10.1093/clinchem/42.5.813Search in Google Scholar
39. Provonost PJ, Nolan T, Zeger S, Miller M, Rubin H. How can clinicians measure safety and quality in acute care? Lancet 2004; 363:1061–7.10.1016/S0140-6736(04)15843-1Search in Google Scholar
40. Plebani M. Towards quality specifications in extra-analytical phases of laboratory activity. Clin Chem Lab Med 2004; 42:578–82.10.1515/CCLM.2004.099Search in Google Scholar PubMed
©2006 by Walter de Gruyter Berlin New York
Articles in the same Issue
- Allergy testing: the role of recombinant allergens
- Autoimmune diagnostics in diabetes mellitus
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
- Autoimmune bullous disorders
- Laboratory network of excellence: enhancing patient safety and service effectiveness
- Novel mutations in the 5′-UTR of the FOLR1 gene
- CYP2C8 polymorphism among the Portuguese
- Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
- Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
- Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
- Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
- Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
- Establishment of an indocyanine green test using an automatic chemistry analyzer
- Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
- Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
- Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
- Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
- Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
- Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
- Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
- Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
- Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
Articles in the same Issue
- Allergy testing: the role of recombinant allergens
- Autoimmune diagnostics in diabetes mellitus
- Diagnosis and prognosis of early rheumatoid arthritis, with special emphasis on laboratory analysis
- Autoimmune bullous disorders
- Laboratory network of excellence: enhancing patient safety and service effectiveness
- Novel mutations in the 5′-UTR of the FOLR1 gene
- CYP2C8 polymorphism among the Portuguese
- Actual levels of soy phytoestrogens in children correlate with thyroid laboratory parameters
- Comparison of the concentration of trace metals (Ni, Zn, Co, Cu and Se), Fe, vitamins A, C and E, and lipid peroxidation in patients with prostate cancer
- Comparison of Brucella immunoglobulin M and G flow assays with serum agglutination and 2-mercaptoethanol tests in the diagnosis of brucellosis
- Experimental and computer modelling speciation studies of the effect of pH and phosphate on the precipitation of calcium and magnesium salts in urine
- Total tau protein, phosphorylated tau (181p) protein, β-amyloid1–42, and β-amyloid1–40 in cerebrospinal fluid of patients with dementia with Lewy bodies
- Establishment of an indocyanine green test using an automatic chemistry analyzer
- Relationship between serum sialic acids, sialic acid-rich inflammation-sensitive proteins and cell damage in patients with acute myocardial infarction
- Ischemia-modified albumin and NT-prohormone-brain natriuretic peptide in peripheral arterial disease
- Nitration of human plasminogen by RAW 264.7 macrophages reduces streptokinase-induced plasmin activity
- Comparison of triglyceride concentration with lipemic index in disorders of triglyceride and glycerol metabolism
- Measurement of glycated hemoglobin (HbA1c) with an automated POCT instrument in comparison with HPLC and automated immunochemistry method: evaluation of the influence of hemoglobin variants
- Analytical performance and clinical efficacy for cardiovascular risk estimation of an Olympus immunoturbidimetric high-sensitivity C-reactive protein assay
- Systemic matrix metalloproteinase-9 (MMP-9) levels as prognostic indexes of bone disease in patients with multiple myeloma
- Systemic levels of matrix metalloproteinase-9 in patients with multiple myeloma may be useful as a prognostic index of bone disease. Reply to the Letter by Demacq and Montenegro
- Society of Medical Biochemists of Serbia and Montenegro: 50-year anniversary
